Schizophrenia is recognized to be a highly heterogeneous disease at various levels, from
genetics to clinical manifestations and treatment sensitivity. This heterogeneity is also …

The immune system is generally known to be the primary defense mechanism against
pathogens. Any pathological conditions are reflected in anomalies in the immune system …

Intravenous administration of immunoglobulins has been routinely used for more than 60
years in clinical practice, developed initially as replacement therapy in immunodeficiency …

During the life of aerobic organisms, the oxygen resulting from numerous reactions is
converted into reactive oxygen species (ROS). Many ROS are dangerous due to their high …

Since the onset of the COVID-19 pandemic, numerous publications have appeared
describing autoimmune pathologies developing after a coronavirus infection, with several …

The S-protein is the major antigen of the SARS-CoV-2 virus, against which protective
antibodies are generated. The S-protein gene was used in adenoviral vectors and mRNA …

Coronavirus disease (COVID-19), caused by the SARS-CoV-2 coronavirus, leads to various
manifestations of the post-COVID syndrome, including diabetes, heart and kidney disease …

Over the last few decades, the advancement in reproductive technologies and protocols to
improve embryo quality through culture techniques and genetic testing to eliminate …

Antibodies recognizing RBD and the S-protein have been previously demonstrated to be
formed in humans after SARS-CoV-2 infection and vaccination with the Sputnik V …

Schizophrenia is known to be accompanied not only with an imbalance in the
neurotransmitter systems but also with immune system dysregulation and chronic low-grade …